Freestyle Libre Available On The NHS April 2019

Wearable glucose monitors will be made available to tens of thousands more people with type 1 diabetes from April 2019, NHS England has announced.
Its decision comes after an investigation found patients in some areas of the country were being denied access to the device.
It reduces the need for finger-prick blood tests and helps people with diabetes to manage their condition.

Diabetes charities called the change of policy a huge step forward.

In England, around 300,000 people have type 1 diabetes.

Under the current system, it is up to the individual clinical commissioning groups (CCGs) to decide whether flash glucose monitoring is available to patients in their area, which means the CCG can dictate the criteria for patients who are eligible for the device, and decide whether they offer it at all.

The device will be funded for people with Type 1 diabetes from 1 April 2019, from next year’s funding growth for local health groups which will allow access to flash monitoring throughout the country.

It is estimated that around 3-5% of patients with Type 1 diabetes in England have access to Freestyle Libre but if clinical commissioning groups (CCGs) were following the guidance correctly, this figure could eventually rise to at least 20-25%. Currently, 144 of 195 clinical commissioning groups have signed up, and today’s announcement mean thousands of patients still missing out will now get access.